$PRXA Cashflow Statement | Understand Stock

$PRXA

$PRXA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash Flows from Operating Activities:
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
Amortization of deferred financing costs and debt discount as interest
Amortization of key money loans
Gain on loan extinguishment
Gain on interest rate swap
Loss on disposal of fixed assets
(Gain) loss on disposal of fixed assets
Changes in operating assets and liabilities:
Accounts receivable
Due from related parties
Prepaid expenses and other assets
Accounts payable, accrued expenses and other
Due to related parties
Net cash provided by operating activities

Cash Flow from Investing Activities:
Acquisition of hotel property, net
Loan receivable funding
Loan receivable payment
Capital improvements
Cash used in investing activities

Cash Flows from Financing Activities:
Proceeds from issuance of common stock
Proceeds from mortgage note
Proceeds from other debt
Payments of mortgage notes principal
Payment of deferred financing costs
Distributions to stockholders
Distributions to noncontrolling interest
Repurchase of common stock
Payment of stockholder servicing fees
Payment of other offering costs to affiliates
Net cash used in financing activities

Increase (decrease) in cash and cash equivalents and restricted cash
Cash and cash equivalents and restricted cash, beginning of period
Cash and cash equivalents and restricted cash, end of period

Comments